Adult; Child; Humans; Administration; Oral; Administration; Topical; Cetirizine; Cetirizine/administration dosage; Cetirizine/adverse effects; Chemotherapy; Adjuvant; Eczema; Eczema/drug therapy; Histamine H1 Antagonists; Histamine H1 Antagonists/administration dosage; Histamine H1 Antagonists/adverse effects; Loratadine; Loratadine/administration dosage; Loratadine/adverse effects; Outcome Assessment (Health Care); Pruritus; Pruritus/drug therapy; Pruritus/etiology; Randomized Controlled Trials as Topic; Terfenadine; Terfenadine/administration dosage; Terfenadine/adverse effects; Terfenadine/analogs derivatives;
机译:口服H1抗组胺药作为湿疹局部治疗的附加疗法
机译:没有高水平的证据支持口服H1抗组胺药作为湿疹的单一疗法:Cochrane系统评价的总结
机译:Bilastine:一种新型的非镇静口服H1抗组胺药,用于治疗变应性鼻结膜炎和荨麻疹
机译:LAS 36674,新一代H1抗组胺药:从长凳到床边和背部
机译:羟嗪和西替利嗪的局部脂质体制剂:在兔模型中评估其理化特性和稳定性以及外周H(1)-抗组胺活性和全身吸收。
机译:没有高水平的证据支持口服H1抗组胺药作为湿疹的单一疗法:Cochrane系统评价的总结
机译:口服H1抗组胺药作为“加载项”治疗肠外治疗湿疹